Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?

Starting soon

Conditions studied: Healthy

In brief

Glucocorticoids and especially cortisol exhibit a pronounced diurnal variation. Levels peak around 8 am and may decrease around two to three times during the day reaching a nadir during the evening and early in the night. Ovulation has been described as a controlled inflammatory event. Following release of the oocyte, termination of the inflammatory reaction needs to take place in order for the follicle and the developing corpus luteum to avoid further damage. It has been suggested, that locally enhanced cortisol availability may play a role in limiting tissue damage and by acting as anti-inflammatory agents mediating repair and remodeling. The aim of the present study is evaluate the concentration of cortisol and cortisone in sets of serum and follicular fluid samples collected simultaneous and at different times of the day (8.00 a.m. and 8.00 p.m.) and compare the levels with the time of the day at which they are collected.

Key facts

Study ID

NCT06877429

Run by

ART Fertility Clinics LLC

People needed

20

Starts

2026-12-30

Expected to finish

2027-12-31

Last updated by the study team

2026-05-07

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Indication for IVF / ICSI - treatment
• Age ≥ 18 years and ≤ 35 years
• Body weight: 19 - 29 kg/m2
• Ovarian reserve parameters in the adequate age - range, determined by Anti-Muellerian-Hormone (AMH) and Antral Follicle Count (AFC) (Shebl 2011, Hamdine 2015)
• Regular cycle (25-35 days)

You may not qualify if…

• Age < 18 years and > 35 years
• Body weight < 60 kg and > 90 kg
• Ovarian reserve parameters outside the adequate age - range, determined by Anti-Muellerian-Hormone (AMH) and Antral Follicle Count (AFC) (Shebl 2011, Hamdine 2015)
• Proven poor responder in preceding IVF-treatment-cycle, according to the Bologna criteria: at least two of the following three features must be present:
• (i) Advanced maternal age (≥40 years) or any other risk factor for POR (poor ovarian response) (ii) A previous POR (≤3 oocytes with a conventional stimulation protocol) (iii) An abnormal ovarian reserve test (i.e. AFC < 5-7 follicles or AMH < 0.5 -1.1 ng/ml)
• Two episodes of POR after maximal stimulation are sufficient to define a patient as a poor responder in the absence of advanced maternal age or abnormal ORT
• Diagnosis of polycystic ovarian syndrome (PCOS), according to Rotterdam criteria
• Endometriosis stage 3 or 4 AFS (American Fertility Society)
• Irregular cycle (< 25 days and > 35 days)
• Treatment with GnRH-analogues during the previous 6 months
• Intake of contraceptive pill (OCP) or any hormonal treatment during the last 3 months

Where it is running

• ART Fertility Clinics LLC — Abu Dhabi, United Arab Emirates

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.